- Home
- IMVT vs OLN Comparison
IMVT vs OLN Comparison
Compare IMVT & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- OLN
- Stock Information
- Founded
- IMVT 2018
- OLN 1892
- Country
- IMVT United States
- OLN United States
- Employees
- IMVT N/A
- OLN N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- OLN Major Chemicals
- Sector
- IMVT Health Care
- OLN Industrials
- Exchange
- IMVT Nasdaq
- OLN Nasdaq
- Market Cap
- IMVT 2.7B
- OLN 2.6B
- IPO Year
- IMVT N/A
- OLN N/A
- Fundamental
- Price
- IMVT $16.16
- OLN $26.39
- Analyst Decision
- IMVT Buy
- OLN Hold
- Analyst Count
- IMVT 11
- OLN 14
- Target Price
- IMVT $33.88
- OLN $25.50
- AVG Volume (30 Days)
- IMVT 1.5M
- OLN 2.2M
- Earning Date
- IMVT 11-06-2025
- OLN 10-23-2025
- Dividend Yield
- IMVT N/A
- OLN 3.03%
- EPS Growth
- IMVT N/A
- OLN N/A
- EPS
- IMVT N/A
- OLN N/A
- Revenue
- IMVT N/A
- OLN $6,663,300,000.00
- Revenue This Year
- IMVT N/A
- OLN $5.64
- Revenue Next Year
- IMVT N/A
- OLN $2.94
- P/E Ratio
- IMVT N/A
- OLN N/A
- Revenue Growth
- IMVT N/A
- OLN 1.49
- 52 Week Low
- IMVT $12.72
- OLN $17.66
- 52 Week High
- IMVT $32.10
- OLN $49.60
- Technical
- Relative Strength Index (RSI)
- IMVT 51.87
- OLN 71.02
- Support Level
- IMVT $16.08
- OLN $22.79
- Resistance Level
- IMVT $17.20
- OLN $25.72
- Average True Range (ATR)
- IMVT 0.77
- OLN 0.90
- MACD
- IMVT 0.16
- OLN 0.30
- Stochastic Oscillator
- IMVT 58.68
- OLN 84.60
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About OLN Olin Corporation
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.